This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, D. D.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 104 No. 6 December 1999, pp. 1345-1350

Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants

Received Mar 10, 1999; accepted Jul 27, 1999.

Diane D. Marshall*, Milton KotelchuckDagger , Thomas E. Young*, §, Carl L. Bose*, Lauree Kruyer§, T. Michael O'Sheaparallel , and the North Carolina Neonatologists Association

From the Departments of * Pediatrics and Dagger  Maternal and Child Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; the § Department of Pediatrics, Wake Area Health Education Center, Raleigh, North Carolina; and parallel  Wake Forest University School of Medicine, Raleigh North Carolina.

Objective.  To identify risk factors for chronic lung disease (CLD) in a population-based cohort of very low birth weight infants, born in an era of surfactant usage. We specifically investigated the effects of antenatal steroids, nosocomial infection, patent ductus arteriosus (PDA), fluid management, and ventilator support strategies.

Methods.  Data were prospectively collected on 1244 infants born in North Carolina in 1994 with birth weights 500 to 1500 g, and treated at 1 of the 13 intensive care nurseries across the state. The outcome of interest was CLD, defined as dependency on supplemental oxygen at 36 weeks' postmenstrual age. Multivariate odds ratios (OR) and 95% confidence intervals (CI) were estimated with logistic regression models.

Results.  Among 865 survivors to 36 weeks' postmenstrual age, 224 (26%) had CLD. Nosocomial infection (OR: 2.0; 95% CI: 1.4-3.3), fluid intake on day 2 (OR: 1.06 per 10 mL increase; 95% CI: 1.01-1.11), and the need for ventilation at 48 hours of life (OR: 2.2; 95% CI: 1.3-3.7) were associated with an increased risk of CLD. Among infants ventilated at 48 hours, nosocomial infection (OR: 1.64; 95% CI: 1.02-2.62) and PDA (OR: 1.9; 95% CI: 1.2-3.1) were associated with an increased risk. No association was found with antenatal steroid receipt or increased levels of ventilator support.

Conclusion.  This analysis suggests that with widespread use of surfactant, nosocomial infection, PDA, and water balance persist as risk factors for CLD.  Key words:  chronic lung disease, bronchopulmonary dysplasia, prematurity, low birth weight, patent ductus arteriosus, betamethasone, infection, ventilation, neonatal factors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 EDUCATION AND PRACTICEHome page
D G Sweet and H L Halliday
The use of surfactants in 2009
Arch. Dis. Child. Ed. Pract., June 1, 2009; 94(3): 78 - 83.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. M. T. Robertson, T. M. Howarth, D. L. R. Bork, and I. A. Dinu
Permanent Bilateral Sensory and Neural Hearing Loss of Children After Neonatal Intensive Care Because of Extreme Prematurity: A Thirty-Year Study
Pediatrics, May 1, 2009; 123(5): e797 - e807.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. Laughon, E. N. Allred, C. Bose, T. M. O'Shea, L. J. Van Marter, R. A. Ehrenkranz, A. Leviton, and for the ELGAN Study Investigators
Patterns of Respiratory Disease During the First 2 Postnatal Weeks in Extremely Premature Infants
Pediatrics, April 1, 2009; 123(4): 1124 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. Noori, M. McCoy, P. Friedlich, B. Bright, V. Gottipati, I. Seri, and K. Sekar
Failure of Ductus Arteriosus Closure Is Associated With Increased Mortality in Preterm Infants
Pediatrics, January 1, 2009; 123(1): e138 - e144.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. McCurnin, S. Seidner, L.-Y. Chang, N. Waleh, M. Ikegami, J. Petershack, B. Yoder, L. Giavedoni, K. H. Albertine, M. J. Dahl, et al.
Ibuprofen-Induced Patent Ductus Arteriosus Closure: Physiologic, Histologic, and Biochemical Effects on the Premature Lung
Pediatrics, May 1, 2008; 121(5): 945 - 956.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
C. L Bose and M. M Laughon
Patent ductus arteriosus: lack of evidence for common treatments
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2007; 92(6): F498 - F502.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
N. Chorne, C. Leonard, R. Piecuch, and R. I. Clyman
Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity
Pediatrics, June 1, 2007; 119(6): 1165 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. C. McCurnin, B. A. Yoder, J. Coalson, P. Grubb, J. Kerecman, J. Kupferschmid, C. Breuer, T. Siler-Khodr, P. W. Shaul, and R. Clyman
Effect of Ductus Ligation on Cardiopulmonary Function in Premature Baboons
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1569 - 1574.
[Abstract] [Full Text] [PDF]

Home page
 J Trop PediatrHome page
G. S. Cunha, F. Mezzacappa-Filho, and J. D. Ribeiro
Risk Factors for Bronchopulmonary Dysplasia in very Low Birth Weight Newborns Treated with Mechanical Ventilation in the First Week of Life
J Trop Pediatr, December 1, 2005; 51(6): 334 - 340.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. A. Ehrenkranz, M. C. Walsh, B. R. Vohr, A. H. Jobe, L. L. Wright, A. A. Fanaroff, L. A. Wrage, K. Poole, and for the National Institutes of Child Health and Hu
Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia
Pediatrics, December 1, 2005; 116(6): 1353 - 1360.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. L. Keller and R. I. Clyman
Persistent Doppler Flow Predicts Lack of Response to Multiple Courses of Indomethacin in Premature Infants With Recurrent Patent Ductus Arteriosus
Pediatrics, September 1, 2003; 112(3): 583 - 587.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. J. Sharek, R. Baker, F. Litman, J. Kaempf, K. Burch, E. Schwarz, S. Sun, and N. R. Payne
Evaluation and Development of Potentially Better Practices to Prevent Chronic Lung Disease and Reduce Lung Injury in Neonates
Pediatrics, April 1, 2003; 111(4): e426 - 431.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. K. Lal, B. N. Manktelow, E. S. Draper, and D. J. Field
Chronic Lung Disease of Prematurity and Intrauterine Growth Retardation: A Population-Based Study
Pediatrics, March 1, 2003; 111(3): 483 - 487.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
M. Avent, D. Coile, and L. Mathai
Neonatal Chronic Lung Disease
Journal of Pharmacy Practice, June 1, 2001; 14(3): 181 - 206.
[Abstract] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A R B. Russell, A J B Emmerson, N Wilkinson, T Chant, D G Sweet, H L Halliday, B Holland, and E G Davies
A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2001; 84(3): 172F - 176.
[Abstract] [Full Text]